chr19-33387165-G-GTAAT
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000285.4(PEPD):c.*178_*179insATTA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 652,862 control chromosomes in the GnomAD database, including 8,242 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1832 hom., cov: 30)
Exomes 𝑓: 0.15 ( 6410 hom. )
Consequence
PEPD
NM_000285.4 3_prime_UTR
NM_000285.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0580
Genes affected
PEPD (HGNC:8840): (peptidase D) This gene encodes a member of the peptidase family. The protein forms a homodimer that hydrolyzes dipeptides or tripeptides with C-terminal proline or hydroxyproline residues. The enzyme serves an important role in the recycling of proline, and may be rate limiting for the production of collagen. Mutations in this gene result in prolidase deficiency, which is characterized by the excretion of large amount of di- and tri-peptides containing proline. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-33387165-G-GTAAT is Benign according to our data. Variant chr19-33387165-G-GTAAT is described in ClinVar as [Benign]. Clinvar id is 328778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.237 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PEPD | NM_000285.4 | c.*178_*179insATTA | 3_prime_UTR_variant | 15/15 | ENST00000244137.12 | ||
PEPD | NM_001166056.2 | c.*178_*179insATTA | 3_prime_UTR_variant | 13/13 | |||
PEPD | NM_001166057.2 | c.*178_*179insATTA | 3_prime_UTR_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PEPD | ENST00000244137.12 | c.*178_*179insATTA | 3_prime_UTR_variant | 15/15 | 1 | NM_000285.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.134 AC: 20372AN: 152012Hom.: 1823 Cov.: 30
GnomAD3 genomes
AF:
AC:
20372
AN:
152012
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.146 AC: 73176AN: 500732Hom.: 6410 Cov.: 6 AF XY: 0.140 AC XY: 36892AN XY: 263282
GnomAD4 exome
AF:
AC:
73176
AN:
500732
Hom.:
Cov.:
6
AF XY:
AC XY:
36892
AN XY:
263282
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.134 AC: 20392AN: 152130Hom.: 1832 Cov.: 30 AF XY: 0.133 AC XY: 9916AN XY: 74376
GnomAD4 genome
AF:
AC:
20392
AN:
152130
Hom.:
Cov.:
30
AF XY:
AC XY:
9916
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
129
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2021 | - - |
Prolidase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at